Todisco Michael 4
4 · DUSA PHARMACEUTICALS INC · Filed May 13, 2011
Insider Transaction Report
Form 4
Todisco Michael
Vice President, Controller
Transactions
- Exercise/Conversion
Common Stock
2011-05-12$1.22/sh+27,800$33,916→ 126,742 total - Sale
Common Stock
2011-05-12$5.94/sh−100$594→ 126,642 total - Sale
Common Stock
2011-05-12$5.94/sh−300$1,782→ 126,342 total - Sale
Common Stock
2011-05-12$5.94/sh−5,000$29,676→ 121,342 total - Sale
Common Stock
2011-05-12$5.93/sh−1,100$6,523→ 120,242 total - Sale
Common Stock
2011-05-12$5.91/sh−300$1,773→ 119,942 total - Sale
Common Stock
2011-05-12$5.91/sh−2,500$14,775→ 117,442 total - Sale
Common Stock
2011-05-12$5.91/sh−5,000$29,537→ 112,442 total - Sale
Common Stock
2011-05-12$5.91/sh−5,000$29,534→ 107,442 total - Sale
Common Stock
2011-05-12$5.90/sh−5,000$29,507→ 102,442 total - Sale
Common Stock
2011-05-12$5.90/sh−3,000$17,703→ 99,442 total - Sale
Common Stock
2011-05-12$5.89/sh−500$2,945→ 98,942 total - Exercise/Conversion
Non-Qualified Stock Option
2011-05-12−27,800→ 0 totalExercise: $1.22From: 2010-03-13Exp: 2016-03-13→ Common Stock (27,800 underlying)